Regeneron Pharmaceuticals Up Over 9%, on Pace for Largest Percent Increase Since November 2016 -- Data Talk
November 05 2019 - 12:29PM
Dow Jones News
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $341.12,
up $30.08 or 9.67%
-- Would be highest close since May 6, 2019, when it closed at
$344.23
-- On pace for largest percent increase since Nov. 9, 2016, when
it rose 13.77%
-- Earlier Tuesday, Regeneron Pharmaceuticals Inc. said its
board authorized the repurchase of up to $1 billion of common
stock
-- The pharmaceutical company reported a third-quarter profit of
$669.6 million, or $5.86 a share, compared with $594.7 million, or
$5.17 a share, a year ago
-- Currently up 10 of the past 11 days
-- Currently up three consecutive days; up 11.37% over this
period
-- Best three day stretch since the three days ending June 22,
2017, when it rose 11.63%
-- Down 8.67% year-to-date; on pace for worst year since 2016,
when it fell 32.38%
-- Down 42.42% from its all-time closing high of $592.40 on Aug.
5, 2015
-- Traded as high as $344.10; highest intraday level since May
6, 2019, when it hit $344.92
-- Up 10.63% at today's intraday high; largest intraday percent
increase since Nov. 9, 2016, when it rose as much as 14.33%
-- Second best performer in the S&P 500 today
-- Best performer in the Nasdaq 100 today
All data as of 12:54:25 PM
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 05, 2019 13:14 ET (18:14 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Jul 2023 to Jul 2024